Artery Research

Volume 20, Issue C, December 2017, Pages 35 - 43

Validation of non-invasive central blood pressure devices: Artery society task force (abridged) consensus statement on protocol standardization

Authors
James E. Sharman*
Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia
Alberto P. Avolio
Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia
Johannes Baulmann
Clinic of Internal Medicine II, University Hospital Schleswig-Holstein, Luebeck, Germany
Athanase Benetos
Département de Médecine Gériatrique, CHRU de Nancy, INSERM U1116, Université de Lorraine, Vandoeuvre-les-Nancy, France
Jacques Blacher
Hypertension and Cardiovascular Prevention Unit, Hôtel-Dieu University Hospital, Assistance Publique-Hôpitaux de Paris, University Paris Descartes, Paris, France
C. Leigh Blizzard
Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia
Pierre Boutouyrie
Departments of Pharmacology, European Georges Pompidou Hospital, Assistance Publique Hôpitaux de Paris, Inserm UMR 970 and University Paris Descartes, Paris, France
Chen-Huan Chen
Department of Medicine, Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan, ROC
Phil Chowienczyk
Department of Clinical Pharmacology, King’s College London British Heart Foundation Centre, UK
John R. Cockcroft
Department of Biomedical Sciences, School of Health Sciences, Cardiff Metropolitan University, Cardiff, UK
J. Kennedy Cruickshank
Cardiovascular Medicine Group, Division of Diabetes and Nutritional Sciences, King’s College, London, UK
Isabel Ferreira
The University of Queensland, School of Public Health, Herston, Brisbane, Australia
Lorenzo Ghiadoni
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
Alun Hughes
Institute of Cardiovascular Science, University College London, UK
Piotr Jankowski
First Department of Cardiology and Hypertension, Institute of Cardiology, Jagiellonian University Medical College, Poland
Stephane Laurent
Departments of Pharmacology, European Georges Pompidou Hospital, Assistance Publique Hôpitaux de Paris, Inserm UMR 970 and University Paris Descartes, Paris, France
Barry J. McDonnell
Department of Biomedical Sciences, School of Health Sciences, Cardiff Metropolitan University, Cardiff, UK
Carmel McEniery
Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, UK
Sandrine C. Millasseau
Pulse Wave Consulting, Saint Leu la Foret, France
Theodoros G. Papaioannou
Biomedical Engineering Unit, First Department of Cardiology, Hippokration Hospital, Medical School, National and Kapodistrian University of Athens, Greece
Gianfranco Parati
Department of Cardiology, S.Luca Hospital, Istituto Auxologico Italiano, Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy
Jeong Bae Park
Department of Medicine/Cardiology, Cheil General Hospital, Dankook University College of Medicine, Seoul, Republic of Korea
Athanase D. Protogerou
Cardiovascular Prevention and Research Unit, Department of Pathophysiology, ‘Laiko’ Hospital, Medical School, National and Kapodistrian University of Athens, Greece
Mary J. Roman
Division of Cardiology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA
Giuseppe Schillaci
Dipartimento di Medicina, Università di Perugia, Unità di Medicina Interna, Ospedale ‘S. Maria’, Terni, Italy
Patrick Segers
IBiTech-bioMMeda, Ghent University, Ghent, Belgium
George S. Stergiou
Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, Third Department of Medicine, Sotiria Hospital, Athens, Greece
Hirofumi Tomiyama
Department of Cardiology, Tokyo Medical University, Tokyo, Japan
Raymond R. Townsend
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Luc M. Van Bortel
Heymans Institute of Pharmacology, Ghent University, Ghent, Belgium
Jiguang Wang
The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
Siegfried Wassertheurer
Austrian Institute of Technology, Health & Environment Department, Vienna, Austria
Thomas Weber
Cardiology Department, Klinikum Wels-Grieskirchen, Wels, Austria
Ian B. Wilkinson
Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, UK
Charalambos Vlachopoulos
First Department of Cardiology, Hippokration Hospital, Medical School, National and Kapodistrian University of Athens, Greece
*Corresponding author. Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia. E-mail address: james.sharman@utas.edu.au
Corresponding Author
James E. Sharman
Received 31 October 2017, Accepted 31 October 2017, Available Online 13 November 2017.
DOI
10.1016/j.artres.2017.11.001How to use a DOI?
Keywords
Guideline; Aorta; Diagnostic equipment; Hypertension; Central blood pressure
Abstract

Brachial cuff blood pressure (BP) is clinically important, but may be an inaccurate substitute for central BP. Many non-invasive devices have been developed that purport to estimate central BP from peripheral artery sites, yet with no standardized guidelines; the accuracy testing of these new devices has not been undertaken in a uniform fashion with comparable protocols. This is an abridged paper describing the recommendations reached by an international task force convened to identify issues that need to be addressed and reach consensus relating to methods for assessing and reporting the accuracy (validation) of central BP devices. The recommendations are endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society, as well as the European Society of Hypertension (ESH) Working Group on Arterial Structure and Function, and the ESH Working Group on Blood Pressure Monitoring and Cardiovascular Variability. Researchers interested in validating central BP monitors should read the full version of the statement.

Copyright
© 2017 Association for Research into Arterial Structure and Physiology. Published by Elsevier B.V. All rights reserved.
Open Access
This is an open access article distributed under the CC BY-NC license.

Download article (PDF)
View full text (HTML)

Journal
Artery Research
Volume-Issue
20 - C
Pages
35 - 43
Publication Date
2017/11/13
ISSN (Online)
1876-4401
ISSN (Print)
1872-9312
DOI
10.1016/j.artres.2017.11.001How to use a DOI?
Copyright
© 2017 Association for Research into Arterial Structure and Physiology. Published by Elsevier B.V. All rights reserved.
Open Access
This is an open access article distributed under the CC BY-NC license.

Cite this article

TY  - JOUR
AU  - James E. Sharman
AU  - Alberto P. Avolio
AU  - Johannes Baulmann
AU  - Athanase Benetos
AU  - Jacques Blacher
AU  - C. Leigh Blizzard
AU  - Pierre Boutouyrie
AU  - Chen-Huan Chen
AU  - Phil Chowienczyk
AU  - John R. Cockcroft
AU  - J. Kennedy Cruickshank
AU  - Isabel Ferreira
AU  - Lorenzo Ghiadoni
AU  - Alun Hughes
AU  - Piotr Jankowski
AU  - Stephane Laurent
AU  - Barry J. McDonnell
AU  - Carmel McEniery
AU  - Sandrine C. Millasseau
AU  - Theodoros G. Papaioannou
AU  - Gianfranco Parati
AU  - Jeong Bae Park
AU  - Athanase D. Protogerou
AU  - Mary J. Roman
AU  - Giuseppe Schillaci
AU  - Patrick Segers
AU  - George S. Stergiou
AU  - Hirofumi Tomiyama
AU  - Raymond R. Townsend
AU  - Luc M. Van Bortel
AU  - Jiguang Wang
AU  - Siegfried Wassertheurer
AU  - Thomas Weber
AU  - Ian B. Wilkinson
AU  - Charalambos Vlachopoulos
PY  - 2017
DA  - 2017/11/13
TI  - Validation of non-invasive central blood pressure devices: Artery society task force (abridged) consensus statement on protocol standardization
JO  - Artery Research
SP  - 35
EP  - 43
VL  - 20
IS  - C
SN  - 1876-4401
UR  - https://doi.org/10.1016/j.artres.2017.11.001
DO  - 10.1016/j.artres.2017.11.001
ID  - Sharman2017
ER  -